pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,879 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 138 phase 2 completion · 64 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion138
  • phase 1 completion64
phase 1 initiation
39
  • phase 2 initiation35
  • phase 1 2 completion29
  • phase 0 trial completion22
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT04907136: Developing and Testing Health Warning Labels on the ENDS Device

    Sponsor: Florida International University. Phase: NA. Conditions: Electronic Cigarette Use

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05208944: THIO Sequenced With Cemiplimab in Advanced NSCLC

    Sponsor: Maia Biotechnology. Phase: PHASE2. Conditions: Carcinoma, Non-Small-Cell Lung

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07554144: The Effect of Body Percussion Training on Neuromotor Performance, Attention, and Functionality in Adolescents With Mild Intellectual Disability

    Sponsor: Kutahya Health Sciences University. Phase: NA. Conditions: Mild Cognitive Impairment, Attention Impaired, Adolescent Development

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05375344: Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp)

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: Urinary Incontinence, Urge

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07215234: A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

    Sponsor: Sanofi. Phase: PHASE1. Conditions: Geographic Atrophy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05776771: The Spine Phenome Project

    Sponsor: Ohio State University. Phase: . Conditions: Low Back Pain, Neck Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06968871: Ameliorated Pap Tests and Cervical Cancer Screening Participation

    Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Cervical Cancer Screening, Cervical Cancer Screening Methods

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01866371: High Resolution Retinal Imaging

    Sponsor: University of Pennsylvania. Phase: . Conditions: Stargardts, Retinitis Pigmentosa, Age-related Macular Degeneration, Choroideremia, Geographic Atrophy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06803771: Surveillance of Pancreatic Health After Diabetes Diagnosis

    Sponsor: University Hospital Southampton NHS Foundation Trust. Phase: NA. Conditions: Diabetes Mellitus, Pancreatic Cancer, Adult

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04704934: Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

    Sponsor: Daiichi Sankyo. Phase: PHASE3. Conditions: Gastric Cancer, Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06622434: New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE1. Conditions: Newly Diagnosed Glioblastoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07433842: Surgery-First Orthognathic Surgery in Skeletal Class III Treatment

    Sponsor: Hanoi Medical University. Phase: NA. Conditions: Skeletal Class III Malocclusion

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07472686: Small Bowel Capsule Endoscopy in Lynch Syndrome

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: MMR Mutation, Small Bowel Adenoma, Small-bowel Adenocarcinoma, Lynch Syndrome, Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04370483: Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma

    Sponsor: City of Hope Medical Center. Phase: EARLY_PHASE1. Conditions: Smoldering Plasma Cell Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02694783: Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells

    Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: EARLY_PHASE1. Conditions: Progressive Multifocal Leukoencephalopathy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04530383: Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

    Sponsor: University of Kansas Medical Center. Phase: PHASE2. Conditions: Cystic Fibrosis-related Diabetes, Cystic Fibrosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03214354: Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

    Sponsor: University of Calgary. Phase: PHASE2. Conditions: Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder, Pure Red Cell Aplasia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07390305: Multidimensional Correlation Study on Skin Aging in Menopausal Women

    Sponsor: ChinaNorm. Phase: . Conditions: Skin Aging, Reproductive Aging, Menopause, Genetic Factors

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07014605: Smoking Cessation Program for Lao People With HIV

    Sponsor: University of Oklahoma. Phase: NA. Conditions: Smoking Cessation, HIV

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06441305: Expanding Coverage of Severe Acute Malnutrition (SAM) Treatment in Kenya

    Sponsor: International Food Policy Research Institute. Phase: NA. Conditions: Acute Malnutrition, Severe, Malnutrition, Child, Wasting

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03484494: Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

    Sponsor: Mclean Hospital. Phase: NA. Conditions: Bipolar Disorder, Bipolar Depression, Bipolar I Disorder, Bipolar II Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06029894: Improving Sleep and AD Biomarkers

    Sponsor: Emory University. Phase: NA. Conditions: Mild Cognitive Impairment, Alzheimer Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04610866: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat

    Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE1. Conditions: Sickle Cell Disease, Hemolytic Anemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07351851: Effects of PEMM in Chronic Low Back Pain Women With Urinary Incontinence

    Sponsor: Hamad Medical Corporation. Phase: NA. Conditions: Chronic Low-back Pain (cLBP), Urinary Incontinence (UI), Pelvic External Myofascial Mobilisation, Myofascial Techniques, Pelvic Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06044051: Dynamics of the Upper and Lower Airway Respiratory Microbiomes Associated With Severe Infant Asthma

    Sponsor: University Hospital, Rouen. Phase: NA. Conditions: Asthma in Children, Asthma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07333131: Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments

    Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Iatrogenic Drug Events

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03794531: Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico

    Sponsor: Harvard School of Public Health (HSPH). Phase: . Conditions: Heart Diseases, Type2 Diabetes, Hypertension, Obesity, Dyslipidemias, Metabolic Syndrome, Cardiovascular Diseases, Chronic Disease, Inflammation, Psychological Stress, Physiological Stress, Depressive Symptoms, Coping Behavior, Diet Habit, Lifestyle, Food Insecurity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06828822: CongenItal Naevus Cohort for Longitudinal Evaluation

    Sponsor: Nantes University Hospital. Phase: NA. Conditions: Naevi, Neurodevelopmental Disorder, Congenital Nevus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02872051: Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and Depression

    Sponsor: Amager Hospital. Phase: NA. Conditions: Generalized Anxiety, Social Phobia, Panic Disorder, Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07293351: A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

    Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Advanced Renal Cell Carcinoma (RCC)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06824129: Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR

    Sponsor: QIAGEN Gaithersburg, Inc. Phase: . Conditions: Complicated Urinary Tract Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05329129: OssDsign® Spine Registry Study ("Propel")

    Sponsor: OssDsign. Phase: . Conditions: Degenerative Disc Disease, Spinal Stenosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06833853: A Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer Patients

    Sponsor: Menarini Silicon Biosystems, INC. Phase: . Conditions: Metastatic Breast Cancer (MBC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT02356653: Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

    Sponsor: Children's Hospital of Philadelphia. Phase: EARLY_PHASE1. Conditions: Leukemia, Inborn Errors of Metabolism, Bone Marrow Failure Syndromes, Immunodeficiencies, Immunodysregulation Polyendocrinopathy Enteropathy X-linked Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07407153: Triaging of Women Detected With a Breast Lump on Clinical Breast Examination Using Portable Ultrasound Device

    Sponsor: International Agency for Research on Cancer. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07285837: Intensive Rehabilitation Program for Upper Limb in Children and Adolescents With Cerebral Palsy

    Sponsor: Fondation Ellen Poidatz. Phase: NA. Conditions: Cerebral Palsy (CP)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06587737: Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage

    Sponsor: Population Health Research Institute. Phase: PHASE3. Conditions: Colchicine, ICH - Intracerebral Hemorrhage, Stroke, Dependence

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03111745: Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010

    Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Viral Infections

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07453095: Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy

    Sponsor: Fondazione Italiana Linfomi - ETS. Phase: PHASE2. Conditions: Mantle Cell Lymphoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07392801: AGE Accumulation in Patients on Long-term Parenteral Nutrition

    Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Chronic Intestinal Insufficiency, Advanced Glycation and Products, Parenteral Nutrition

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06906601: Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study.

    Sponsor: Centre Leon Berard. Phase: . Conditions: Breast Cancer, Medico-economic Impact, Breast Cancer Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05885412: A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)

    Sponsor: Rocket Pharmaceuticals Inc.. Phase: PHASE1. Conditions: PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05711719: Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

    Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Metabolic Syndrome, Coronary Microvascular Dysfunction

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06929975: The Effect of Podcast Training on Birth Fear in Couples

    Sponsor: Istanbul University - Cerrahpasa. Phase: NA. Conditions: Pregnancy, Birth Fear

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05806801: Metabolic Adaptations to Weight Loss With and Without Exercise

    Sponsor: University of Michigan. Phase: NA. Conditions: Obesity, Metabolic Disease, Metabolic Syndrome, Insulin Sensitivity, Insulin Resistance, Weight Loss

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03847701: Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients

    Sponsor: Mondelēz International, Inc.. Phase: NA. Conditions: Type2 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07095712: Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS

    Sponsor: n-Lorem Foundation. Phase: PHASE1. Conditions: Amyotrophic Lateral Sclerosis

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06068400: Clinical Study to Evaluate the Safety and Efficacy of CAR-T in the Treatment of Relapsed or Refractory Multiple Myeloma

    Sponsor: Guangzhou Bio-gene Technology Co., Ltd. Phase: NA. Conditions: Relapsed or Refractory Multiple Myeloma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07487207: Effects of Augmented Reality Functional Integrated Training (AR-FIT) on Balance and Mobility in Stroke

    Sponsor: Riphah International University. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07578792: Standard vs Dual-Task Hand-Arm Bimanual Training in Post-Stroke Patients

    Sponsor: Riphah International University. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ← prev
    page 22 of 98
    next →